HK1105200A1 - Materials and methods for treating coagulation disorders - Google Patents

Materials and methods for treating coagulation disorders

Info

Publication number
HK1105200A1
HK1105200A1 HK07110493.4A HK07110493A HK1105200A1 HK 1105200 A1 HK1105200 A1 HK 1105200A1 HK 07110493 A HK07110493 A HK 07110493A HK 1105200 A1 HK1105200 A1 HK 1105200A1
Authority
HK
Hong Kong
Prior art keywords
sub
compounds
methods
materials
salts
Prior art date
Application number
HK07110493.4A
Other languages
English (en)
Inventor
Pascal Druzgala
Cyrus Becker
Original Assignee
Armetheon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/822,129 external-priority patent/US7145020B2/en
Application filed by Armetheon Inc filed Critical Armetheon Inc
Publication of HK1105200A1 publication Critical patent/HK1105200A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
HK07110493.4A 2004-04-08 2007-09-27 Materials and methods for treating coagulation disorders HK1105200A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56112104P 2004-04-08 2004-04-08
US10/822,129 US7145020B2 (en) 2001-04-24 2004-04-08 Materials and methods for treating coagulation disorders
PCT/US2005/012091 WO2005100336A1 (en) 2004-04-08 2005-04-08 Materials and methods for treating coagulation disorders

Publications (1)

Publication Number Publication Date
HK1105200A1 true HK1105200A1 (en) 2008-02-06

Family

ID=34965219

Family Applications (2)

Application Number Title Priority Date Filing Date
HK07110493.4A HK1105200A1 (en) 2004-04-08 2007-09-27 Materials and methods for treating coagulation disorders
HK10103549.8A HK1138265A1 (en) 2004-04-08 2010-04-12 Materials and methods for treating coagulation disorders

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK10103549.8A HK1138265A1 (en) 2004-04-08 2010-04-12 Materials and methods for treating coagulation disorders

Country Status (18)

Country Link
US (1) US7285671B2 (ja)
EP (1) EP1735296B1 (ja)
JP (1) JP5036532B2 (ja)
KR (1) KR101203124B1 (ja)
AT (1) ATE451361T1 (ja)
AU (1) AU2005233614C1 (ja)
BR (1) BRPI0508392A (ja)
CA (1) CA2559568C (ja)
CY (1) CY1109763T1 (ja)
DE (1) DE602005018181D1 (ja)
DK (1) DK1735296T3 (ja)
ES (2) ES2340690T3 (ja)
HK (2) HK1105200A1 (ja)
IL (1) IL178122A (ja)
NO (1) NO338837B1 (ja)
PT (1) PT1735296E (ja)
RU (1) RU2495034C2 (ja)
WO (1) WO2005100336A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE388143T1 (de) * 2001-04-24 2008-03-15 Aryx Therapeutics Cumarin derivate und ihre verwendung als anticoagulantien
DK2161261T3 (da) * 2004-04-08 2013-11-04 Armetheon Inc Materialer og fremgangsmåder til behandling af koagulationslidelser
EP1954669B1 (en) * 2005-12-01 2015-07-08 Auspex Pharmaceuticals, Inc. Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
CN101188435B (zh) * 2007-01-08 2011-03-16 中兴通讯股份有限公司 一种比特交织装置与方法
RU2010143600A (ru) 2008-03-26 2012-05-10 Дайити Санкио Компани, Лимитед (Jp) Производное гидроксихиноксалинкарбоксамида
US9549912B2 (en) 2009-11-23 2017-01-24 Armetheon, Inc. Methods for treating atrial fibrillation
US20110136779A1 (en) * 2009-11-23 2011-06-09 Milner Peter G Methods for stroke reduction in atrial fibrillation patients
CA2781888C (en) 2009-12-11 2019-06-18 Nono Inc. Agents and methods for treating ischemic and other diseases
JP5639665B2 (ja) 2010-02-12 2014-12-10 エヌサーティー・ファーマシューティカルズ・インコーポレーテッド Ｓ−ニトロソグルタチオンレダクターゼのクロモン阻害剤
BR112012019529A2 (pt) 2010-02-12 2019-09-24 N30 Pharmaceuticals Llc inibidores de d-nitrosoglutationa redutase
US10292982B2 (en) 2014-01-15 2019-05-21 Southern Methodist University Inhibitors of multidrug resistance transporter P-glycoprotein
US9561227B2 (en) 2014-01-15 2017-02-07 Southern Methodist University Inhibitors of multidrug resistance transporter P-glycoprotein
US11013739B2 (en) 2014-01-15 2021-05-25 Southern Methodist University Inhibitors of multidrug resistance transporter p-glycoprotein
US11234978B2 (en) 2014-01-15 2022-02-01 Southern Methodist University Inhibitors of multidrug resistance transporter P-glycoprotein
CN114524791B (zh) * 2022-01-26 2024-01-26 江苏慧聚药业股份有限公司 替卡法林的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108459A0 (en) * 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
GB9324517D0 (en) * 1993-11-30 1994-01-19 Octel Chem Ltd Process for the preparation of substituted 4-hydroxycoumarins
FR2749585B1 (fr) * 1996-06-11 1998-08-14 Hoechst Marion Roussel Inc Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
FR2807032B1 (fr) * 2000-03-29 2003-04-18 Warner Lambert Co Modification de la chimioselectivite lors de l'oxydation de composes organiques azotes
US7145020B2 (en) * 2001-04-24 2006-12-05 Aryx Therapeutics Materials and methods for treating coagulation disorders
ATE388143T1 (de) * 2001-04-24 2008-03-15 Aryx Therapeutics Cumarin derivate und ihre verwendung als anticoagulantien
EP1438297A1 (en) * 2001-10-10 2004-07-21 Aryx Therapeutics Mibefradil-based compounds as calcium channel blockers useful in the treatment of hypertension and angina
US7179838B2 (en) * 2002-07-30 2007-02-20 New Century Pharmaceuticals, Inc. Coumarin analog compounds for safer anticoagulant treatment

Also Published As

Publication number Publication date
EP1735296A1 (en) 2006-12-27
CA2559568A1 (en) 2005-10-27
HK1138265A1 (en) 2010-08-20
AU2005233614C1 (en) 2012-07-19
AU2005233614A1 (en) 2005-10-27
PT1735296E (pt) 2010-02-09
IL178122A (en) 2013-01-31
WO2005100336A1 (en) 2005-10-27
RU2495034C2 (ru) 2013-10-10
CA2559568C (en) 2013-05-28
KR20060133081A (ko) 2006-12-22
US7285671B2 (en) 2007-10-23
IL178122A0 (en) 2006-12-31
US20060287388A1 (en) 2006-12-21
JP5036532B2 (ja) 2012-09-26
ES2436298T3 (es) 2013-12-30
KR101203124B1 (ko) 2012-11-20
RU2008120295A (ru) 2009-11-27
DE602005018181D1 (de) 2010-01-21
AU2005233614B2 (en) 2011-11-24
ATE451361T1 (de) 2009-12-15
CY1109763T1 (el) 2014-09-10
NO338837B1 (no) 2016-10-24
EP1735296B1 (en) 2009-12-09
DK1735296T3 (da) 2010-02-01
NO20065079L (no) 2006-11-03
BRPI0508392A (pt) 2007-08-07
JP2007532575A (ja) 2007-11-15
ES2340690T3 (es) 2010-06-08

Similar Documents

Publication Publication Date Title
HK1138265A1 (en) Materials and methods for treating coagulation disorders
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
HK1091121A1 (en) Substituted 2-aminotetralins for the treatment of depressions
SG170828A1 (en) Deazapurines useful as inhibitors of janus kinases
NO20052595L (no) Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser.
NO20082508L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
EA200501936A1 (ru) Производные пиридо[2,1-a]изохинолина в качестве ингибиторов dpp-iv
TW200613306A (en) Imidazotriazines as protein kinase inhibitors
DE602004011394D1 (en) Thiazolderivate
ATE427926T1 (de) Cycloalkylaminderivate
AU2003225800A1 (en) Azolylaminoazine as inhibitors of protein kinases
AU2003220299A1 (en) Azinylaminoazoles as inhibitors of protein kinases
AU2003220300A1 (en) Compositions useful as inhibitors of protein kinases
NO20064976L (no) Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
WO2006067165A3 (en) Indolidone derivatives for the treatment or prevention of fibrotic diseases
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
TW200740787A (en) (6-Fluoro-benzo[1,3]dioxolyl)-morpholin-4-yl-methanones
SE0403006D0 (sv) New compounds
SE0202462D0 (sv) Novel use
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
TW200621765A (en) Substituted phenylaminothiazoles and their use
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
WO2007024843A3 (en) Pyrimidinyl-pyrazole inhibitors of aurora kinases
NO20082096L (no) Azaindol-2-karboksamidderivativer